To meet the intent of the award mechanism, applications must address at least one of the FY22 CPMRP Investigator-Initiated Research Award (IIRA) Focus Areas. Selection of the appropriate focus area is the responsibility of the applicant.
Chronification of pain ○ Understanding mechanisms of, and developing models for studying, the transition from acute to chronic pain following trauma either physical and/or psychological ○ Development of mechanistically justified therapies to prevents and treat chronification ○ Identifying risk or protective factors or biomarkers for patients susceptible to chronification, including relevant subpopulations ○ Investigating relationships between pain and its co-morbidities that can contribute to the development/progression of chronic pain
Effectiveness or observational studies of novel treatments or untested techniques/approaches/pathways to chronic pain management ○ Pilot/preliminary studies ○ Potential clinical effectiveness
Development of non-opioid therapies and methods of the treatment of chronic pain ○ Novel non-opioid pharmacological solutions ○ Devices that treat chronic pain directly ○ Devices that improve the administration of non-opioid analgesics
Additionally, the incorporation of one or more of the following into the proposed research approaches is encouraged but not required: Pain informatics Pragmatic approaches Patient expectations, preference, and goals of treatment at point of care Multiple ecological levels of stakeholder engagement in the study design with human participants High prevalence in military populations including Service Members, Veterans, and beneficiaries. Established models of pain assessments that include pain interference in emotional and physical functioning
Investigators at or above the level of Assistant Professor (or equivalent) may be named by the organization as the PI or Partnering PI on the application. An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by, or affiliated with, an eligible organization.
The anticipated direct costs budgeted for the entire period of performance for an FY22 CPMRP IIRA will not exceed $900,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.